Ana Gallego, Mayte Serrat, Estíbaliz Royuela-Colomer, Juan P Sanabria-Mazo, Xavier Borràs, Montserrat Esteve, Mar Grasa, Araceli Rosa, Antoni Rozadilla-Sacanell, Miriam Almirall, Francesco D'Amico, Yifei Dai, Michael J Rosenbluth, Lance M McCracken, Jaime Navarrete, Albert Feliu-Soler, Juan V Luciano
OBJECTIVE: Fibromyalgia (FM) is a prevalent pain syndrome with significant healthcare and societal costs. The aim of the SMART-FM-SP study is to determine the effectiveness, cost-utility, and physiological effects in patients with FM of a digital intervention (STANZA®) currently marketed in the United States, which delivers smartphone-based, fully self-guided Acceptance and Commitment Therapy (Digital ACT) for treating FM-related symptoms. METHODS: A single-site, parallel-group, superiority, randomized controlled trial (RCT) will be conducted, including a total of 360 adults diagnosed with FM...
2024: Digital Health